Comeback to a pre-injury level disappointing for professional baseball players
SAN FRANCISCO Only 45 percent of baseball players were able to return to the game at the same or higher level after shoulder or elbow surgery, according to new research released today during the 2008 American Orthopaedic Society for Sports Medicine Specialty Day at The Moscone Center. In an ...Shares Of AVI BioPharma Drops On Reports Of Disappointing Early Drug Trail
Shares of AVI BioPharma Inc. has lost a third of their value on Wednesday after the company reported disappointing clinical trial data for its experimental treatment against the hepatitis C virus. // The shares of AVI were down $2.43, or 33 percent, to $4.83, in the heavy morning trade on t...Outcome of Animal Studies on Treatment for Herpes Keratitis, Disappointing
Doylestown - Quigley Pharma Inc. conducted animal studies to test its treatment against Herpes Keratitis, when the herpes simplex virus attacks the eye. The test results// revealed that the treatment did not prove successful when tested on animals. Quigley explained that tests conducted to ga...FDA Ruling on Mercury Fillings Falls Short
...elines fail to protect pregnant women and children from threat of "silver" dental fillings WASHINGTON, July 28 /PRNewswire-USNewswire/ -- In a disappointing move, the Food and Drug Administration (FDA) today did an about face in issuing a final regulation classifying dental amalgam without calling for stri...Neuronal survival and axonal regrowth obtained in vitro
...on of voluntary motor activity through axonal re-growth has long been considered impossible in mammals. Over the last decade, numerous attempts proved disappointing overall. The Inserm team led by Alain Privat has recently shown that an essential component interfering with regeneration was due to the activity of a...Personality May Not Predict Parkinson's
... found no link between the kinds of personalities people had in their younger years and their risk of developing Parkinson's. The second finding is disappointing because it appears to mean that doctors won't have a potential tool to predict the disease, said Dr. Walter A. Rocca, a professor of epidemiology and ...Press Releases on BPA Studies By-Pass Scientific Process
...abstracts. Bypassing the scientific process in favor of sensational press releases is a scare tactic that will not promote public health. "It is disappointing to see that some researchers continue to inject animals with bisphenol A since this experimental technique has recently been acknowledged by the Natio...Most Cancer Treatment Studies Aren't Published, Study Finds
...udies, nearly two-thirds had "positive" results-the study treatment worked as hoped. The remaining one-third had "negative" results -- the outcome was disappointing or did not merit further consideration of the tested treatment. This finding raises concern about "publication bias" in cancer treatment trials. The...ViroPharma Announces Discontinuation of HCV-796 Development
... of HCV-796 due to the previously announced safety issue that emerged in the ongoing Phase 2 trial in patients with hepatitis C. "Clearly, this is a disappointing outcome for patients suffering from this difficult disease," commented Vincent Milano, ViroPharma's president and chief executive officer. "Significan...AIDS Vaccine Advocacy Coalition Voices Disappointment in Trial Result
...an three years later. Getting swift, precise answers about candidates is crucial for the field. In this sense, the STEP Study fulfilled its purpose-as disappointing as the results may be. One reason for this efficiency is that both STEP and its companion trial Phambili, which tested the candidate in South Africa,...Conor Medsystems, LLC Reports COSTAR II Pivotal Drug-Eluting Stent Trial Conclusions
...most widely studied coronary stent in the world. "While the safety data from this trial are consistent with other drug-eluting stent studies, it was disappointing that this product did not meet the high standards for efficacy that our product portfolio represents," said Rick Anderson, Johnson & Johnson Compa...Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
... changes returning to baseline during off therapy periods they preclude exploration of higher doses of OE. "Unfortunately, the study results were disappointing but definitive," said Douglas Abel, president and chief executive officer of Manhattan Pharmaceuticals. "With all our development programs, Manhattan ...SMOS and Proba-2 launch rescheduled for November
...e we can start the launch campaign and start shipping the satellite and support equipment to the launch site in Russia. Although the delay is a little disappointing the team is very much looking forward to launch in November." SMOS, or ESA's Water Mission as it is known, will make global observations of soil m...Cell's split personality is a major discovery into neurological diseases
...s the glutamate receptors on neurons triggering massive calcium entry and cell death. However, clinical trials targeting glutamate receptors have been disappointing suggesting that these receptors play only a minor role in triggering neuronal death. The study, supported by the Canadian Institutes of Health Rese...Skin cancer study uncovers new tumor suppressor gene
...educe their action, while those aimed at tumor suppressor genes seek to restore or increase their action. The new study may help to explain the disappointing performance of drugs designed to treat cancer by blocking MMP enzymes. Because members of the MMP gene family were thought to be oncogenes and many tu...Animal eggs not suitable substitutes to produce stem cells
...ry important paper suggests that livestock oocytes are extremely unlikely to be suitable as recipients for use in human nuclear transfer. This is very disappointing because it would mean that production of patient-specific stem cells by this means would be impracticable," says Ian Wilmut, Ph.D., Editor-in-Chief of...Intraspinal implant of mesenchymal stem cells may not heal the demyelinated spinal cord
...ot lead to remyelination. Once more, we found that the MSCs migrated into areas of normal tissue and were associated with axonal damage." Despite the disappointing results of this study, Dr. Hunt feels that further experimentation with directly implanted MSCs is still called for since a variety of other MSC popul...A double-barreled immune cell approach for neuroblastoma
...y and their numbers can increase, said Brenner. Previous attempted to use T-lymphocytes with an artificial receptor directed to tumor cells proved disappointing because they disappeared from the body too quickly to have an anti-cancer effect. However, cytotoxic T cells that already have a natural receptor for ...Cataloguing invisible life: Microbe genome emerges from lake sediment
...uencing samples of seawater, it was an ambitious project to use genetics to understand invisible ecological communities. But his scientific legacy was disappointing a jumble of mystery DNA fragments belonging to thousands of unknown organisms. Now a team led by a University of Washington scientist has studied...New technology for boosting vaccine efficiency
...b.- A modified protein with disrupted structure would provide protein segments for antigen presentation and thus be a stronger immunogen. However, the disappointing news was just ahead. The readily proteosome degradable proteins were not better vaccines than their wild type counterparts. The same problem was encou...GPhA Calls Senate HELP Committee Action Disappointing for Countless Patients
ARLINGTON, Va., July 13 /PRNewswire-USNewswire/ -- The Generic Pharmaceutical Association (GPhA) released the following statement today from GPhA President and CEO Kathleen Jaeger on the Senate HELP Committee's vote on biogenerics legislation. "While we are extremely disappointe...SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
...llion in accounts receivable. "This recent period has been a challenging time for SEQUENOM. Our announcement at the end of April was immensely disappointing and has resulted in a setback in our molecular diagnostics programs. However, I believe we are at a point where we can look forward to other promising...Heart disease: Research off the beating patch
...art muscle than conventional cell transplantation techniques, in which cells are injected directly into the heart. "I think the main reason for the disappointing results people have seen with those clinical trials is that the cells end up in an environment that is not optimal for them to thrive in. Scar tissue ...Essilor : First Half 2009 Revenue
...Xperio(TM) polarized lens in the United States. - Firm growth in entry-level products, where Essilor holds strong positions. - A disappointing first-quarter performance in instruments. The strong 6% growth from changes in the scope of consolidation primarily reflects a 3.2% increase ...Nanopillars promise cheap, efficient, flexible solar cells
... charge carriers. "Unfortunately, early attempts to make photovoltaic cells based on pillar-shaped semiconductors grown from the bottom-up yielded disappointing results. Light-to-electricity efficiencies were less than one to two percent," says Javey. "Epitaxial growth on single crystalline substrates was ofte...Now Available: State-of-the-Art Gait Training Device to Help Millions Walk More Normally Again
...le in the US have diseases or conditions that affect their ability to walk. For many of them, traditional walking aids such as canes and walkers are a disappointing substitute for being able to walk normally and live independently. Now there's a high-tech yet easy-to-use gait-training device, the GaitAid Virt...Amylin Co-Founder Announces Plans to Vote for Eastbourne Slate
...hallenges. I believe management will have more freedom to think outside of the box if we replace the directors most directly involved in crafting the disappointing commercialization strategy. Also, with the departures of Ginger Graham and me, the Amylin board loses more than 60% of its stock ownership. I th...ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results
...lion, which includes cash, cash equivalents and short-term investments of $276 million. "While, clearly the early part of 2009 produced disappointing clinical results for maribavir, 2008 was a very successful year for ViroPharma -- from strong financial results to great execution in all aspects of o...Animal Eggs Not Suitable Substitutes to Produce Stem Cells
...ry important paper suggests that livestock oocytes are extremely unlikely to be suitable as recipients for use in human nuclear transfer. This is very disappointing because it would mean that production of patient-specific stem cells by this means would be impracticable," says Ian Wilmut, Ph.D. , Editor-in-Chie...USC researchers print dense lattice of transparent nanotube transistors on flexible base
...m-tin oxide electrodes which function as sources, gates and drains. Earlier attempts at transparent devices used other semiconductor materials with disappointing electronic results, enabling one kind of transistor (n-type); but not p-types; both types are needed for most applications. The critical improvemen...